Abstract
Background
Fatty degenerative osteonecrosis of the jawbone (FDOJ), also referred to as jawbone cavitations or bone marrow defects (BMD), is characterized by ischemic fatty degeneration, impaired bone remodeling, and chronic overexpression of inflammatory mediators, particularly the chemokine RANTES/CCL5. Emerging clinical observations suggest that FDOJ/Cavitations may exert systemic effects through neuroimmunological mechanisms, potentially influencing autonomic nervous system (ANS) regulation and cardiovascular function.
Objective
This retrospective observational study explored whether postoperative patient-reported improvement in cardiovascular or autonomic symptoms was documented in a subset of patients following surgical debridement of FDOJ/Cavitations, while primarily characterizing histopathological evidence of peripheral nerve involvement in these lesions.
Methods
In a retrospective cohort, 16 patients reported subjective improvement in cardiovascular symptoms and ANS symptoms following surgical debridement of FDOJ/Cavitations. However, these outcomes were based on non-standardized patient self-reports without systematic cardiological evaluation.
Results
In an analysis of 1,958 histological reports from patients who had undergone FDOJ/cavitation surgery, collected between 2008 and 2020 at a surgical center in Munich, Germany, these findings revealed the presence of scar-associated nerves in 84 cases (=4%). From this cohort, 31 patients (age 53–81 years) were selected for further detailed evaluation based on consistent neural alterations within the lesions. In all 31 FDOJ/Cavitation samples, histological analysis revealed pathological alterations of peripheral nerves, including perineural fibrosis, irregular axonal sprouting, accessory or aberrant nerve formations, and scar neuromas. Conventional radiographic methods often failed to detect FDOJ/Cavitations, whereas trans alveolar ultrasound sonography showed higher diagnostic sensitivity.
Conclusion
These findings suggest that peripheral nerve alterations may represent a relevant component of the pathology of FDOJ/Cavitations and raise the hypothesis of potential neuroimmune–autonomic interactions. Due to methodological limitations, the observations remain hypothesis-generating and require confirmation through prospective interdisciplinary studies with objective cardiovascular and autonomic assessments.
Keywords: osteonecrosis of the jawbone, FDOJ, bone marrow pathology, nerve regeneration, Chemokine CCL5, neuroimmunomodulation, autonomic nervous system, peripheral nerves, ultrasonography, TAU
Graphical Abstract

Introduction
Fatty degenerative osteonecrotic jawbone (FDOJ) lesions—also termed “Cavitations”1—are pathological changes primarily involving the medullary compartment of the jaw.2 Histopathology reveals reduced trabecular density, fatty marrow transformation, impaired microcirculation, and adipocyte degeneration.3 Although several mechanisms have been proposed to explain the development of post-extraction jawbone cavitations,4 their pathogenesis remains unclear. These include incomplete or altered socket healing and remodeling after tooth extraction, impaired local microcirculation resulting in chronic ischemic or hypoxic tissue changes, and disturbances in bone and marrow homeostasis.5 While the combination of reduced trabecular bone, adipose tissue degeneration and fibrotic or myxoid remodeling is consistent with chronic tissue injury, it does not establish a single causal mechanism. Osteoimmune dysregulation and altered inflammatory signaling, including the increased expression of RANTES/CCL5 reported in FDOJ specimens, have also been suggested as contributing factors.6 Elevated expression of proinflammatory mediators, particularly RANTES/CCL5, suggests dysregulated inflammatory signaling.6 These hypotheses should be regarded as competing or potentially complementary models rather than proven mechanisms of cavitation formation. Accordingly, the concepts of FDOJ and jawbone cavitation remain debated, with opposing findings appearing in the critical literature. This includes Sekundo et al’s systematic review7 and Dominiak et al’s critical discussions.8
Within the framework of osteoimmunology, bone and immune cells (eg, osteoblasts, osteoclasts, T and B lymphocytes, macrophages) interact bidirectionally.9 Clinically, FDOJ/Cavitations lesions may be asymptomatic or present with nonspecific symptoms and are frequently undetectable on conventional two-dimensional radiographs, as medullary changes may lack distinct imaging features.10 Corresponding cone beam 3D imaging showed no or minimal abnormalities, whereas ultrasound and intraoperative findings revealed yellowish, softened, discolored cancellous bone.11
Figure 1 illustrates these findings (European tooth numbering): Panel (A) shows the retromolar region of tooth 48 with unremarkable radiography, while panel (B) demonstrates marked medullary alteration. Compared with healthy jawbone (C),4 affected tissue (D) exhibits reduced mineralized trabeculae and increased fatty marrow.2 Panel (E) further shows structural disorganization and degenerative medullary changes.
Figure 1.

Upper panels: The left (A) shows the retromolar area of tooth 48 (area is indicted in white circle) with radiographic findings that appear unremarkable on conventional imaging. In contrast, the right (B), obtained following the application of contrast medium, demonstrates the extent of medullary bone loss in the same region, highlighting alterations not visible on standard radiography. Lower panels: Histological evaluation of medullary jawbone (examples not from A and B): Healthy control bone tissue (C) in comparison with pathohistological FDOJ/Cavitations tissue sample (D) and morphological tissue sample (E) and (D): “The central areas of the lesion (‘cavitation’) show marked degeneration of adipose tissue. Adipocytes are partially lost and replaced by a loose, fine fibrillary extracellular matrix with myxoid features. Residual adipocytes are embedded within delicate fibrillary connective tissue. The findings are consistent with chronic trophic disturbance, possibly related to impaired microcirculation and chronic hypoxia.”* *Gemeinschaftspraxis für Pathologie and Zytologie Dr.med. Zwicknagl, Dr.med. Aßmus. 85356 Freising, Germany.
Emerging but limited evidence suggests that FDOJ/Cavitations lesions may have effects beyond the local orofacial region. Lechner et al (2021) and subsequent studies reported increased expression of RANTES/CCL5 in affected tissue, raising the hypothesis of a contribution to systemic inflammatory signaling.11 Given the role of CCL5 in immune cell recruitment and chronic inflammation,9 potential systemic implications warrant further investigation. Although prior work has suggested osteoimmunological and inflammatory abnormalities in FDOJ/Cavitations,9 direct evidence linking these lesions to cardiovascular dysregulation is currently lacking. Such considerations may be relevant in the context of cardiovascular disease — the leading cause of mortality in Western countries.12
The primary objective of this study was to characterize histopathological alterations related to the peripheral nerves in surgically removed FDOJ/Cavitation specimens. The secondary, exploratory objective was to retrospectively document cases in which patients reported an improvement in cardiac or autonomic symptoms following surgery. Any putative neuroimmune-autonomic relevance therefore remains speculative and requires cautious interpretation.
Materials and Methods
Surprisingly after FDOJ/Cavitations surgery 16 patients reported in letters a subjective postoperative change in cardiovascular or autonomic symptoms. This guided us to evaluate histopathology of peripheral nerve alterations in a total analysis of 1,958 histological reports after FDOJ/Cavitation, collected between 2008 and 2020 at a Munich clinic. Out of this group a total number of 84 patients (= 4%) were analyzed as scar accessory nerves, which are nerve fibers or nerve bundles located within or in close association with fibrotic tissue in the FDOJ. Their presence may indicate neural remodeling, but does not by itself demonstrate a functional or causal relationship with clinical symptoms. 31 patients showed „Axon sprouting of peripheral nerves/nerve branches” in the FDOJ/Cavitations samples. The discussion Further enlightens the connections from axon sprouting and complex regional pain syndrome (CRPS) in FDOJ/Cavitations to subjective postoperative change in cardiovascular or autonomic symptoms.
Study Design and Cardiovascular Case Assessment
Clinical observations, particularly in integrative dental practice, have described subjective improvement of systemic symptoms in cardiac complaints following surgical debridement; however, these reports remain anecdotal. One proposed mechanism involves persistent local inflammation influencing autonomic regulation, including sympathetic overactivation. Surgical removal of chronically altered medullary tissue may be hypothesized to influence neuroimmune interactions, potentially restoring autonomic balance. In this context, following the surgical removal of FDOJ/Cavitations lesions,1–9 we identified 16 subjective reports of atrial and ventricular complaints improvement in patients from 2008 to 2020, categorized under “AV better”. However, these observations are retrospective, non-standardized, and do not allow any causal or clinical conclusions.
These subjective reports were classified in Table 1 according to the degree of improvement, ranging from complete resolution of symptoms (100%) to partial improvement (50%). Notably, two of these patients (12,5%) reported immediate improvement (IT), nine of these patients (56,25%) reported short-term positive effects (ST) shortly after FDOJ/Cavitations debridement. In the remaining five patients (31,25%), neurovascular stabilization occurred more gradually, over a period of several months, resulting in long-term positive outcomes (LT). These 16 patients reported postoperative cardiac outcomes and subjective improvements (see Table 1). All 16 cases met the histopathological inclusion criteria.
Table 1.
Statistical Overview of Study Data
| Case ID | ANS Change | Time Course | FDOJ Neur | FDOJ Area | Main Histo | OPG FDOJ | CBCT FDOJ | TAU FDOJ |
|---|---|---|---|---|---|---|---|---|
| S.R | y | Delay | y | 18–19 | PN, PSF | n | y | y |
| H.G. | y | Imm | y | 28-27 | PN, PSF | n | n | y |
| C.B. | y | Delay | y | 17-19 | NB, SNM | n | n | y |
| A.G. | y | Delay | y | 48-49 | PN, PSF | n | n | y |
| M.H. | y | Imm | y | 27-28 | NB, IS | n | y | y |
| G.H. | y | Early | y | 38-39 | NB, IS, SNM | n | n | y |
| R.A. | y | Imm | y | 28-29 | PN, PSF | n | n | y |
| S.A. | y | Delay | y | 28-29 | NB, PSF | n | n | y |
| N.L. | y | Imm | y | 38-39 | PN | n | n | y |
| E.K. | y | Early | y | 18-19 | PN, PSF | n | y | y |
| K.A. | y | Imm | y | 37-38 | PN, PSF, IS | y | y | y |
| H.V. | y | Delay | y | 38-39 | NB, deg | n | n | y |
| K.S. | y | Early | y | 14-15 | NB, deg | n | x | y |
| K.A. | y | Imm | y | 28-29 | NB, vit | n | y | y |
| R.I. | y | Early | y | 35-38 | NB, PSF | n | y | y |
| W.E. | y | Imm | x | x | x | n | n | y |
| L.N. | y | Delay | x | 23-24 | x | n | n | y |
| L.C. | y | Delay | x | x | x | n | n | x |
| W.T | y | Imm | y | 48-47 | PN, IS, SNM | n | y | x |
| K.H. | x | x | y | 38-39 | PN, AcN | n | n | x |
| M.S. | x | x | y | 38-39 | NB, PSF | n | n | x |
| A.W. | x | x | y | 48-49 | PN, PSF | n | y | y |
| B.I. | x | x | y | 18-19 | PN, PSF | n | x | y |
| V.O. | x | x | y | 25-26 | PN, PSF | n | n | y |
| N.Y. | x | x | y | 46-48 | PN, PSF, IS | n | x | y |
| N.E. | x | x | y | 18-19 | NB, vit | n | n | y |
| K.X. | x | x | y | 38-39 | NB, vit | n | n | x |
| P-D. | x | x | y | 48-49 | PN, PSF, IS, SNM | n | n | x |
| C.F. | x | x | y | 48-49 | NB, IS | n | y | y |
| H.A. | x | x | y | 38-39 | PN, PSF | n | n | y |
| J.E. | x | x | y | 48-49 | PN, PSF | n | n | x |
Notes: Case ID = 31 patients; ANS (Autonomic nerve system) change = ANS patient-reported postoperative symptom improvement: yes/x = no report; ANS change = 19 patients; Reported time course and estimated symptom change of 23 patients: (Immediate = imm/ early / delayed = delay /x = not documented.) Immediate = 8 patients; early = 4 patients; delayed = 7 patients; FDOJ Neuro = FDOJ samples with pathohistological finding on existing peripheral nerve sprouting: y/x = no report; FDOJ samples = 28 patients; FDOJ Area = area of FDOJ/Cavitations surgery and debridement = 29 patients; OPG FDOJ suggestive FDOJ/Cavitations (y/n = detectable/ not detectable.) Visibility on OPG = 1 patient; CBCT FDOJ suggestive FDOJ/Cavitations (y/n = detectable/not detectable.) Visibility on CBCT = 9 patients; TAU FDOJ (y/x = detectable/ no report.) Ultrasonographic imaging of FDOJ bone marrow defect = 24 patients. x = no report.) Immediate term refers to an immediate relief within days. Early term refers to a short time period of several days until weeks. Delayed term refers to a long time period of weeks until months.
Abbreviations: Main Histo, Main histopathological neural features; PN, peripheral nerve; NB, nerve branches; PSF, perineural sheath fibrosis; can, accessory nerve; IS, irregularly sprouting; SNM, Scar neuroma.
Cardiovascular symptoms included palpitations, documented arrhythmias, episodic tachycardia and neurovegetative dysregulation with cardiac manifestation are displayed in three cases. Postoperative outcomes were categorized as immediate improvement (days, immediate term), early improvement (days–weeks, short term), delayed improvement (weeks–months, long term) and no reported improvement (no) (see Table 1). Time and improvement are shown in Table 1 in % of improvement. Outcomes were based on patient-reported documentation.
Patient Reported Postoperative Symptom Improvement - Cases
A subset of three cases meeting predefined histopathological and documentation criteria was included. These three patients provided written informed consent for their case details to be published.
Case #1
The first case concerns a patient who presented with tachycardia and underwent FDOJ/Cavitations surgery. In October 2008, long-term ECG documented sinus rhythm with brief episodes of atrial tachycardia (up to 13 seconds), and beta-blocker therapy was recommended. By May 2012, following FDOJ/Cavitations surgeries, cardiological evaluation reported no persistent or severe arrhythmias, no syncope, and no stress-induced angina. The patient additionally reported reduction of symptoms, resorption of prior pericardial effusion, and only occasional low-dose beta-blocker use, which she associated with FDOJ/Cavitations surgery. The accompanying pathology report in this case states: Specimen composed of a peripheral nerve structure with preserved, vital nerve fibers. Findings are consistent with an accessory nerve branch. No inflammatory infiltrate identified.
Case #2
A second case involved a patient with long-standing cardiac arrhythmia refractory to beta-blocker therapy and a scheduled pacemaker implantation. Preoperative radiography showed no apparent jawbone abnormalities (Figure 2). Surgical exploration, however, revealed fatty degenerative changes of the mandibular bone. Following uncomplicated postoperative healing, the patient reported improvement in cardiovascular symptoms and subsequently canceled the planned pacemaker implantation. The accompanying pathology report in this case states: Peripheral nerve exhibiting marked perineural fibrosis and disorganized regenerative axonal proliferation, consistent with a traumatic (scar) neuroma.
Figure 2.

(A and B) illustrate the difference between inconspicuous radiological finding (area is indicated by red arrow) and the contrast-enhanced intraoperative imaging of fatty degenerative softening of the medulla (two areas are indicated by red arrows) in this cardiovascular case. (C) shows a characteristic example of the fatty degenerative morphology (black arrow) of a FDOJ/Cavitations area.
Case #3
The patient reports: „I was diagnosed with cardiac arrhythmia, which was treated with strong medication, including TAMBOCO (Flecainidacetat) and CORDAREX (Amiodaron). However, the results were negligible. The heart specialist Dr. D. diagnosed a double heartbeat. After clean up of FDOJ, my heart problems immediately improved, and after about three days, my heart was beating normally again.” The accompanying pathology report in this case states: Excavated specimen containing a minute arteriovenous hemangioma embedded in fibrous scar tissue. Adjacent viable peripheral nerve branches are present, showing perineural fibrosis. The remaining bone exhibits fatty marrow with fibrotic changes and areas of fat necrosis accompanied by resorptive activity (osteoclastic remodeling).
Due to the reliance on subjective reports and the absence of detailed treatment data, important confounders remain unaddressed. These include baseline cardiology diagnosis and disease severity, comorbidities, changes in antiarrhythmic or beta-blocker medication before and after treatment, and intercurrent treatments or interventions. In addition, no standardized cardiac monitoring protocol was applied and no standardized cardiovascular follow-up protocol or objective autonomic assessment was available.
Surgical Procedure and Histopathological Analysis
For FDOJ/Cavitations surgery after local anesthesia, a mucoperiosteal flap was elevated and cortical access to the medullary cavity was performed. FDOJ/Cavitations bone marrow tissue was removed via curettage. Specimens were submitted for histopathological evaluation and were examined by certified oral pathologists and cited as narrative pathology reports. All FDOJ/Cavitations bone samples were obtained during surgical debridement of suspected jawbone lesions and examined under light microscopy using standard hematoxylin–eosin staining.
Exclusion and Inclusion Criteria
Patients with active odontogenic abscess, acute osteomyelitis, or systemic inflammation at the time of surgery were excluded. Histopathological inclusion criteria in all cases were peripheral nerve structures, perineural fibrosis, irregular axonal sprouting, accessory nerve formations, neuroma-like changes, adipocyte degeneration and fibrotic remodeling.
Ethics Statement
FDOJ/Cavitations specimens were obtained from patients undergoing surgical debridement of pathological jawbone marrow at the authors’ clinic, all seeking evaluation for possible chronic jawbone inflammation.13 This patient-centered retrospective case-series control study was classified and exempted by the Institute for Medical Diagnostics (IMD Berlin) in accordance with DIN EN 15198/DIN EN 17025. All patients provided written informed consent for publication. Samples and data were collected during routine care and analyzed retrospectively; standard medical treatment was unchanged, and no additional institutional approval was required for publication. Data were anonymized or pseudonymized, and clinical images were fully de-identified. Patients continued symptom-relief medications as needed. No identifiable information is disclosed. The study complied with the Declaration of Helsinki.
Results
The results are based on observations from a selected case series and are intended to inform prospective investigations, rather than providing evidence of a confirmed neuroimmune or cardiovascular mechanism. A case-selection flow shows the retrospective database of 1,958 histology reports from 2008 to 2020, the 84 reports (4.3%) documenting findings classified in the original records as scar-associated accessory nerve findings, and the 31 cases selected for detailed descriptive analysis. The 31 cases were selected based on report completeness and the required diagnostic and neural findings. They should not be interpreted as representative of all patients undergoing FDOJ/Cavitations surgery.
Histopathological Findings
This retrospective study is inspired by the retrospectively documented postoperative patient reports collected between 2008 and 2020. Accordingly, we analyzed 1,958 histological findings from a single surgical center in Munich, Germany during the period mentioned above. The pathology material consisted of routine narrative reports by certified pathologists.14 As the original review was not conducted using a prospective, standardized scoring protocol, we explicitly state this and do not describe the assessments as standardized or blinded.
Histopathological examination of all resected specimens confirmed features of FDOJ/Cavitations. Among these 1,958 FDOJ/Cavitations cases, 84 patients (4%) showed consistent clinical and histopathological findings described as “scar-access.nerv (Scar-Accessory Nerv)”. Figure 3 summarizes the histological documentation from 2008–2020 and illustrates the occurrence of these pathological changes, characterized as traumatic scar neurinomas with accessory nerve formations following dental surgery. Figure 4 shows the distribution of histopathological findings in 31 patients.
Figure 3.

The bars show: Histology Findings (=100%) of 1958 FDOJ/Cavitations specimen with specific definitions in %: Metabolic Disturbance (=85%), Myxoid Degeneration (=56%), Fibrillar Degeneration (45%), Necrotic Adipose Tissue (=43%), Necrotic Fat Tissue (=25%), Scar-AccessNerv (=4%; marked in red as main subject in the paper), Reparative bone remodeling (=46%), No Inflammation (=94%) and Negative Histology (=2,5%) as the rate of misdiagnosis in FDOJ/Cavitations specimen. Multiple answers are possible.
Figure 4.

Pathohistological findings: All 28 retrospectively analyzed patients listed (exception x), are differentiated to the following histological technical terms (from the bottom up): PN = peripheral nerve: 16 patients = 57,14%; NB = nerve branches: 12 patients = 42,86%; PSF = perineural sheath fibrosis: 16 patients = 57,14%; AcN = accessory nerve: 1 patient = 3,57%; IS = irregularly sprouting: 7 patients = 25%; SNM = Scar neurinoma: 4 patients = 14,29%; vit/deg = vital or degenerated: 3 patients vital nerv branches = 10,71% and 2 patients degenerated nerv branches = 7,14%.
From this cohort, 31 patients were selected (age 53–81; 12 male, 19 female) for detailed descriptive analysis based on report completeness and consistent documentation of neural alterations. All showed similar histological features involving peripheral nerves within FDOJ/cavitation samples (see Figure 4). Histopathological evaluation* assessed peripheral nerve structures, perineural fibrosis, irregular axonal sprouting, accessory nerve formations, neuroma-like changes, adipocyte degeneration, and fibrotic remodeling.
*(Gemeinschaftspraxis für Pathologie and Zytologie Dr. med. Zwicknagl, Dr. med. Aßmus; 85354 Freising, Germany).
Critical Imaging in the Interpretation of FDOJ/Cavitation Bone Lesions
When selecting the cases, the reliability of the imaging in depicting FDOJ/Cavitation bone lesions was also taken into account. A critical review shows that only one OPG (y) clearly indicates FDOJ/Cavitations medullary bone defects.10 CBCT improved visualization but remained inconclusive in 13 cases (n). TAU suggested altered bone density patterns in most evaluated patients (26), except two cases without TAU (x). TAU ultrasound sonography was not available for two patients, however when performed (n = 26), it generally provided a clear indication for FDOJ/Cavitations debridement, confirmed by the conspicuous neural histology of the sample.
The study was not designed as a diagnostic-accuracy study. Without claiming diagnostic sensitivity, specificity, or superiority over OPG or CBCT imaging availability and interpretation were retrospective. Any comparison between imaging and histology is presented as descriptive and limited to the cases with both data types available.
Statistical Overview
This retrospective case series was designed for descriptive analysis and was not powered to test inferential hypotheses. Categorical findings are reported as counts and percentages with the denominator stated. No inferential statistical tests were performed.
Table 1 summarizes patient-reported cardiovascular outcomes and changes in autonomic symptoms, as well as the available exploratory clinical observations. The structure is organized according to case ID, documented patient-reported postoperative cardiac/autonomic symptom change (yes/no/x = not documented) (= ANS change), reported time course of symptom improvement (immediate = imm/ early / delayed = delay /x = not documented) (= Time course), main histopathological neural features in FDOJ/Cavitations specimen (FDOJNeur), FDOJ/Cavitations location (= FDOJ area), OPG suggestive (yes/no) (= OPG FDOJ), CBCT suggestive of FDOJ/Cavitations (yes/no/x = inconclusive) (= CBCT FDOJ) and as a final assessment TAU suggestive (yes/no/x = not available) (= TAU FDOJ).
Descriptive statistics: Among patients undergoing jawbone surgery, the presence of, or greater extent of, histologically identified peripheral nerve alterations — such as axonal sprouting, perineural fibrosis, or neuroma-like changes — is possibly associated with a higher prevalence or severity of autonomic or cardiovascular symptoms, after adjustment for relevant confounders. The null hypothesis is therefore retained.
Discussion
The autonomic and immune systems interact in the regulation of the cardiovascular system.12 While evidence linking inflammation to heart rate variability is inconclusive, inflammatory signaling may influence autonomic activity and sympathetic nerve remodelling.15,16 Therefore, the coexistence of jawbone nerve alterations and autonomic or cardiovascular symptoms warrants investigation, but does not prove causation.
This study identified frequent peripheral nerve alterations within FDOJ/Cavitations lesions and a temporal association between surgical debridement and subjective cardiovascular symptom improvement in a subset of patients. These clinical observations should be interpreted with caution due to the retrospective design, the absence of standardized outcome assessment, and the high risk of recall, expectation, and confounding bias.
Peripheral Nerves and Odontogenic Trauma
The histological abnormalities observed, are reflected in the clinical findings of the two FDOJ/Cavitations cases shown in Figure 5. The morphology of the two peripheral nerves with perineural sheath fibrosis is clearly identifiable, whereas the OPG 2D radiographs alone reveal no anatomical abnormalities in the retromolar regions of the surgical sites 48 and 38 (Figure 5). The presence of perineural fibrosis and axonal sprouting suggests altered local wound healing processes.
Figure 5.

Left window, top (A): After exposure and opening of a cortical window in region 48, finely branched nerve fibers are visible within the area of medullary bone loss, without any connection to the inferior alveolar nerve or its branches (white circle). Left window, bottom (B): During elevation of the mucoperiosteal flap, the emergence of a peripheral nerve is already visible, branching into periosteal extensions (white circle). Right windows (C and D): The radiographs show no anatomical abnormalities in the retromolar areas 48 or 38 (white circles). Pathohistological finding, upper left window (A): Histopathology area 48/49 (white circle): ‘Myxoid, degeneratively altered adipose tissue containing small peripheral nerve branches. In the proximal segments, the nerve fibers still show preserved Schwann cells, whereas the distal segments exhibit degenerative changes consistent with axonal degeneration.” Pathohistological finding, lower left window: Histopathology area 38/39 (B): ‘Peripheral nerve tissue with preserved nerve fibers. The endoneurium demonstrates increased collagen deposition consistent with endoneurial fibrosis, and the perineurium is thickened and fibrotic. Overall findings are consistent with a peripheral (accessory) nerve.
Histology of Peripheral Nerve Alterations
Thanks to J.E. Bouquot’s earlier histological work on histopathological features in FDOJ/Cavitations*we are able to present images here that are highly relevant to the issue at hand. Figure 6 shows, for reference, an unaltered neural structure embedded in unremarkable adipose tissue.
Figure 6.

(Source: Prof. JE Bouquot) Typical alveolar nerve (blue arrow) shows good, smooth-walled demarcation from the surrounding fatty tissue, without pressure from individual fat cells and no splitting of the individual fibers.* Dropbox „TroubledBones”; Dr. J.E. Bouquot, Director of Research. Maxillofacial Center for Education and Research. 212 Tibbs Road, Morgantown, WV 26508. bouquot@aol.com.
In contrast the following images (Figures 7–9) show examples of such pathologically altered tissue describing ischemic nerve injury with axonal splitting, traumatic neurinoma formation, and perineural fibrosis — features that overlap with the alterations observed in the present FDOJ/Cavitations specimens as shown in Figure 7 (Source: JE Bouquot):
Figure 7.

(Source: JE. Bouquot) Ischemic nerve damage with splayed, frayed nerve fibers partially enclosed within the bony nerve canal. The inferior alveolar nerve is located in an ischemic damaged lower jaw. The axon is split and irregular, with a knot of traumatic neurinoma-like thickening (white arrow). The bony wall of the alveolar canal (yellow arrows) is very thin, and the alveolar vessels are atrophied.
Figure 8.

(Source: JE Bouquot) Small traumatic neurinomas (black arrow) on the surface of a damaged nerve, with partially enlarged cell nuclei as a dysregulated healing response associated with axon sprouting.
Figure 9.

(Source: JE. Bouquot) Myelin staining reveals areas of unusual nerve hyperplasia and constrictions with focal bulging along the nerve pathways (yellow arrows), resembling a traumatic neurinoma that develops on the surface of the nerve, resulting in varying degrees of reparative excessive myelin degeneration (JE Bouquot).
Figure 8 displays a comparable image of small traumatic neurinomas on the surface of a damaged nerve, with partially enlarged cell nuclei associated with axon sprouting (Source: JE Bouquot):
Similarly, in Figure 9 myelin staining reveals areas of unusual nerve hyperplasia resembling a traumatic neurinoma that develops on the surface of the nerve (Source: JE Bouquot):
Axon Sprouting and Complex Regional Pain Syndrome (CRPS) in FDOJ/Cavitations
Normally after neural trauma, recovery occurs via axon regeneration (regrowth along original pathways) or axon sprouting (collateral branching of intact neurons). Figure 10 contrasts physiological regeneration with injury-induced peripheral sprouting observed in FDOJ/Cavitations histology (Figure 5).
Figure 10.

Difference between physiological neural regeneration(A) and (B) injury-induced peripheral sprouting16 (red lines in A and B and red circle in (B) as demonstrated by the FDOJ/Cavitations histological findings presented.
Chronically overactive sympathetic fibers lead to persistent constriction of small blood vessels. This vasoconstriction further impairs blood flow, exacerbating the ischemic tissue condition within the medullary space of FDOJ/Cavitations and even promoting progression toward necrosis.17 Concurrently, immunomodulatory processes occur, as sympathetic neurotransmitters such as norepinephrine influence immune cells within the bone marrow. These pathophysiological mechanisms and their physiological effects—vasoconstriction, sympathetic–afferent coupling with sensory pain fibers, and immunomodulation—are also known to occur in other chronic pain syndromes, such as complex regional pain syndrome (CRPS).18
CRPS is considered a systemic neuroinflammatory disorder marked by autonomic dysregulation, sympathetic overactivation and long-term post-traumatic autonomic imbalance.19 We hypothesize that CRPS development may parallel the progression of FDOJ/Cavitations in the jawbone, after dental surgical trauma by aseptic ischemic osteonecrosis with Th2/Type2–mediated inflammation.17 This chronic impairment of bone regeneration may induce peripheral sympathetic axon sprouting,19 with new nerve branches extending into degenerative jawbone areas and potentially affecting the peripheral nervous system.20
The Role of Noradrenaline in CRPS
Current research indicates that the neurotransmitters noradrenaline (NA) and acetylcholine (ACh) are involved in the pathophysiology of CRPS. These neurotransmitters, released from sympathetic and parasympathetic nerve endings, also exert modulatory effects on the development and activity of osteoclasts.21 In vivo studies have demonstrated that NA and ACh exert opposing effects on bone homeostasis: NA signaling is preferentially associated with a low–bone mass phenotype.22,23 In vitro studies using murine and human osteoclast-like cells have shown expression of α- and β-adrenoceptor mRNA, as well as enhanced osteoclastogenesis following β-adrenoceptor agonism.24,25 Research on sympathetic axon sprouting has further demonstrated that inflammation or tissue injury can trigger a neuroplastic response, leading to increased sprouting of sympathetic nerve fibers that release NA and thereby influence immune cells. NA inhibits Th1/Type1 cells via β2-adrenoceptors and promotes differentiation toward Th2/Type2 cells. Consequently, increased sympathetic sprouting may contribute to a shift toward a Th2/Type2-dominant immune response.26,27
Axon Sprouting and Enhancement of Immunological Activity in FDOJ/Cavitations
Literature demonstrates that inflammatory mediators and chemokines can influence nerve growth and autonomic signaling. While elevated RANTES/CCL5 cytokine expression has been reported in FDOJ/Cavitations tissue in previous studies,2,28,29 chemokines such as RANTES/CCL5 have been shown to directly affect neural cells through mechanisms of neural plasticity.30 Via CCL5 receptors expressed on glial cells, macrophages, and neurons, RANTES/CCL5 can induce nerve growth factor (NGF) and other neurotrophic factors (Figure 11).31 NGF, in turn, represents a key mediator of sympathetic axon sprouting.20 Local RANTES/CCL5 over expression might induce neurotrophic factors such as NGF, promote sympathetic axon sprouting, increase local noradrenaline release and modulate the immune response toward a Th2/Type2-dominant profile (Figure 11).27
Figure 11.

Existing chronic inflammation is further exacerbated by RANTES/CCL5 (upwards black arrow), which promotes sympathetic axon sprouting through upregulation of nerve growth factor (NGF) (upwards black arrow), resulting in increased noradrenaline release (upwards black arrow), further modulating the Th2/Type2 immune response to chronic down regulation (downwards red arrow).
Our earlier FDOJ/Cavitations investigations consistently demonstrate a pronounced Th2/Type2 immune response in the characteristic cytokine profile.28,29 This may result in an interaction between sympathetic axon sprouting and a Th2/Type2 immune response within the jawbone marrow (Figure 11). As bone marrow contains numerous hematopoietic cells regulated by cytokines, chronic local inflammatory processes within a Th2/Type2 dominated environment may promote persistent inflammation.3 This immunomodulatory pathological shift contributes to reinforcing the neurovegetative component. This study did not directly measure cytokine levels or autonomic function. Thus, any proposed neuroimmune-autonomic interaction remains hypothetical, depending on narrative reports of symptom reduction.
Imaging Considerations
The following two clinical examples out of 31 patients of the study illustrate the radiographically cryptic structure of FDOJ/Cavitations axon sprouting compared with ultrasound imaging. The trans-alveolar ultrasonography device (TAU) indicates degenerative changes in the alveolar medullary regions in red/orange, while healthy bone density is shown in green.30
The first example (Figure 12) highlights the diagnostic gap associated with standard dental radiography: Both the OPG (A) of regions 37–39 and the corresponding CBCT longitudinal section (B) show no indication for surgical intervention. Only the sagittal section of region 37/38 (C) visualizes a medullary bone scar. In contrast, ultrasound imaging reveals incomplete wound healing in this area without the need for radiation exposure or patient burden and prior to the performance of a complex and sometimes inconclusive CBCT analysis (Figure 12). Surgical debridement of the area yielded the following pathohistological findings: Histopathology area 38/39: Angular excision from the oral cavity with a normally structured peripheral nerve showing slight, loosely arranged perineural sheath fibrosis.
Figure 12.

Upper windows, from left to right: The images show a medullary bone scar that is not clearly apparent in radiography (A and B) (red circles). The scar is only visible in the cross-sectional view (C) (red arrow), although this alveolar pathology is not visible neither on the 2D panoramic X-ray (A) nor on the 3D DVT X-ray (B) (red circles). Lower window, left: In contrast, ultrasound sonography immediately reveals the conspicuous scarring (highlighted in red/Orange) in the alveolar regions 37–39. Bone density measurement around the healthy tooth 37 shows no abnormalities (highlighted in green).
Figure 13 provides the second example, illustrating the visual contrast between the radiologically unremarkable region 18/19 (yellow circle) and the fatty degenerative dissolution of the bone structure, with residual vital cancellous trabeculae visible in the morphologically documented FDOJ/Cavitations specimen (right window). In contrast, the reduced bone density highlighted in red/orange in regions 18/19 and in green in area 17 identifies tooth 17 as having normal bone density. A third aspect that does not correspond to the radiographic findings is the pathohistological result: Histopathology area18/19: The medullary spaces show degenerative adipocyte damage with fibrillar degeneration. A small peripheral nerve with perineural fibrosis (possibly pain-related) and fatty tissue exhibiting trophic disturbance are also involved (Figure 13).
Figure 13.

Upper left window (A): The 2D OPG reveals no radiographic abnormalities or evidence of medullary osteonecrosis (yellow circle). In contrast, the right window (B) demonstrates the fatty degenerative morphology of alveolar areas 19–18. Lower three windows (left): Ultrasound sonography shows (C) degenerative changes in the alveolar regions 19–18 in red/Orange. The measurement of preserved bone density around the healthy tooth 17 is shown in green (D).
Radiation-Free Ultrasound Sonographic Imaging of Bone Density
The results in Table 1 show, that conventional radiography demonstrated limited sensitivity for medullary alterations, while TAU appeared more sensitive in imaging conspicuous jawbone densities.31–33 Conventional dental radiographs are primarily evaluated through visual interpretation by the clinician, based on professional experience and pattern recognition to assess potential bone loss or structural changes in the jaw.32 Consequently, the interpretation is optical and partly subjective, as it depends on the individual examiner’s assessment. In contrast, ultrasound sonography of the jaw can be used to obtain quantitative measurements related to bone density.32–34 The resulting data is displayed using color-coded visualization, allowing different density levels within the jawbone to be represented objectively (see Figure 13). This approach therefore relies more strongly on measurable parameters rather than solely on visual interpretation.35
The discrepancy between the absence of radiographic evidence of localized medullary alveolar osteonecrosis and its clinical manifestations —particularly neuralgic facial pain—is not a new phenomenon.36 However, due to the previously mentioned limits of radiographic imaging, the extensive literature on this topic has not achieved broader scientific recognition.36 Rather, it has underscored the need to develop novel imaging modalities for the detection of focal osteonecrotic jawbone lesions. Since 2002, attention has focused on through-transmission alveolar ultrasound sonography (TAU).31–35 In addition to developments at the German University Dental Hospital in Mainz, this has led to the creation of a globally unique TAU device for the practical, non-invasive assessment of jawbone quality.32–34
Potential Translational Relevance
Overactive sympathetic fibers may induce persistent vasoconstriction, leading to impaired blood flow and potentially contributing to an aseptic ischemic state of the jawbone.2,5–10,37 Clinically relevant immunomodulation is evident in some specific FDOJ/Cavitations: Sympathetic neurotransmitters, such as norepinephrine, influence immune cells within the bone marrow and modulate inflammatory activity and contributes to the Th2/Type2 shift in FDOJ/Cavitations.3 Inhibition of sympathetic adrenergic signaling through surgical clearance may represent a potential area for future investigation, as peripheral immune activation associated with the Th2/Type2 shift in FDOJ/Cavitations has been linked to axon sprouting–driven neuroinflammation.3,17–23
Limitations and Challenges of the Study
The cardiovascular/autonomic component of this study should be interpreted strictly as descriptive and exploratory, as no standardized diagnostic criteria, validated symptom instruments, or objective cardiological/autonomic outcome measures were available. Because prior dental procedures and their dates were not systematically recorded, this study cannot establish a temporal or causal relationship between an earlier extraction or surgery and the histopathological findings.
The study does not provide prospective evidence and remains clearly hypothesis-generating. The TAU observations are therefore presented as descriptive, and no diagnostic-performance claim is made. Verification remains challenging because tissue samples are not routinely examined histologically or immunohistochemically for axon sprouting. “Improvement” in arrhythmias/palpitations is mainly patient-reported and expressed in broad percentage categories and short-term/long-term labels. These retrospectively documented patient-reported outcomes make the study vulnerable to recall and expectation bias and limits interpretability, although they are anchored to objective documentation of pathohistological assessment and preoperative imaging. In an earlier paper, we compiled pathohistological data from osteonecrotic jawbone (FDOJ) samples taken from 15 patients with neuropathic facial pain.36 Here, we present pathological changes to the peripheral nerves observed in 35 patients, where perineural fibrosis, axonal sprouting and scar neuromas are associated with neuroimmune interactions of the autonomic nervous system (ANS), manifesting as symptoms such as palpitations and tachycardia. Future research should prioritize heart rate variability (HRV), arrhythmia frequency and severity, and structured follow-up assessments to determine whether surgical removal of FDOJ/Cavitations pathology results in measurable improvements in cardiovascular dysautonomia. Such investigations should be conducted through interdisciplinary collaboration between dental surgical centers and cardiology/neurology departments, as the present data do not demonstrate that FDOJ/Cavitations cause autonomic dysregulation or cardiovascular disease, nor that surgical debridement results in measurable cardiovascular benefit.
Conclusion
This retrospective case series describes peripheral nerve-related findings in selected jawbone specimens and retrospective patient-reported postoperative cardiovascular or autonomic symptom changes. These non-standardized observations cannot establish a treatment effect or causal relationship. The findings are hypothesis-generating and are limited by retrospective case selection, narrative pathology reports, incomplete clinical documentation, and the absence of a control group or objective cardiovascular and autonomic measurements. The findings support the hypothesis that neural components may be relevant in the pathophysiology of FDOJ/Cavitations. The retrospective patient reports cannot establish causality or treatment effect. Prospective studies using predefined selection criteria and standardized histopathological and clinical assessment are needed.
Acknowledgments
The authors would like to thank Prof. JE Bouquot for kindly and generously providing his histological images.
Funding Statement
This research received no external funding.
Data Sharing Statement
The authors declare that all relevant data supporting the findings of this review are included in this article. For further requests, the corresponding author should be contacted.
Author Contributions
All authors made a significant contribution to the work reported, whether that is in the conception, study design, execution, acquisition of data, analysis and interpretation, or in all these areas; took part in drafting, revising or critically reviewing the article; gave final approval of the version to be published; have agreed on the journal to which the article has been submitted; and agree to be accountable for all aspects of the work.
Disclosure
Johann Lechner holds patents PCT/EP2018/084199 and PCT/EP2020/058962 relating to the TAU apparatus discussed in this study. This interest is relevant to the interpretation of the imaging observations. The present study was not designed to validate TAU or establish its diagnostic accuracy. The patent interest does not relate to the histopathological assessment or the retrospective patient-reported cardiovascular outcomes. The authors report no other conflicts of interest in this work.
References
- 1.Ghanaati S, Śmieszek-Wilczewska J, Al-Maawi S, Heselich A, Sader R. After extraction, upper premolars undergo programmed socket collapse with development of cavitations rather than complete socket healing: a radiological study. Bioengineering. 2025;12:128. doi: 10.3390/bioengineering12020128 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Ghanaati S, Dohle E, Schick F, Lechner J. Quantitative real-time RT-PCR verifying gene expression profile of cavitations within human jaw bone. Biomedicines. 2025;13:1144. doi: 10.3390/biomedicines13051144 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Lechner J, von Baehr V, Notter F, Schick F. Osteoimmune interaction and TH1/TH2 ratio in jawbone marrow defects: an underestimated association. Biologics. 2024;18:147–17. doi: 10.2147/BTT.S448587 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Ghanaati S, Kamalov A, Bouquot J, Sader R, Heselich A, Al-Maawi S. Covered Socket Residuum (CSR) in Former Third Molar Sockets Despite Platelet-Rich Fibrin: a Prospective Randomized Controlled Split-Mouth Clinical Study. Bioengineering. 2025;12(11):1242. doi: 10.3390/bioengineering12111242 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Heselich A, Najafi R, Alammawi S, Śmieszek-Wilczewska J, Ghanaati S. Alveolar ridge preservation revisited: a multimodal evaluation of bone preservation and regeneration—preliminary findings from a randomized controlled clinical trial. Bioengineering. 2026;13(4):447. doi: 10.3390/bioengineering13040447 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Lechner J, von Baehr V. RANTES and fibroblast growth factor 2 in jawbone cavitations: triggers for systemic disease? Int J Gen Med. 2013;6:277–290. doi: 10.2147/IJGM.S43285 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Sekundo C, Wiltfang J, Schliephake H, et al. Neuralgia-inducing cavitational osteonecrosis – a systematic review. Oral Dis. 2022;28:1448–1467. doi: 10.1111/odi.13886 [DOI] [PubMed] [Google Scholar]
- 8.Dominiak M, Niemczyk W, Pitułaj A, ´swienc W, Matys J. Fatty degenerative osteonecrosis of the jaw: bridging molecular insights and clinical practice—a scoping review. Int J Mol Sci. 2025;26:1853. doi: 10.3390/ijms26051853 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Lechner J, von Baehr V. Chemokine RANTES/CCL5 as an unknown link between wound healing in the jawbone and systemic disease: is prediction and tailored treatments on the horizon? Epma j. 2015;6:10. doi: 10.1186/s13167-015-0032-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Lechner J. Validation of dental X-ray by cytokine RANTES: comparison of X-ray findings with cytokine overexpression in jawbone. Clin Cosmet Investig Dent. 2014;6:71–79. doi: 10.2147/CCIDE.S69807 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Lechner J, Schmidt M, von Baehr V, Schick F. Undetected jawbone marrow defects as inflammatory and degenerative signaling pathways: chemokine RANTES/CCL5 as a possible link between the jawbone and systemic interactions. J Inflamm Res. 2021;14:1603–1612. doi: 10.2147/JIR.S307635 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Carnevale D. Neuroimmune axis of cardiovascular control: mechanisms and therapeutic implications. Nat Rev Cardiol. 2022;19:379–394. doi: 10.1038/s41569-022-00678-w [DOI] [PubMed] [Google Scholar]
- 13.Vasconcelos e Cruz J, Perko S, Doebis C, Notter F, Schick F, Lechner J. Could silent inflammation originating in jawbone cavitations play a role in activating the CCL5/CCR5 axis in female breast cancer? Onco Targets Ther. 2025;18:1053–1068. doi: 10.2147/OTT.S526033 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Schick F, Lechner J, Notter F. Linking dentistry and chronic inflammatory autoimmune diseases—can oral and jawbone stressors affect systemic symptoms of atopic dermatitis? Int Med Case Rep J. 2022;15:323–338. doi: 10.2147/IMCRJ.S367434 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Williams DP, Koenig J, Carnevali L, et al. Heart rate variability and inflammation: a meta-analysis of human studies. Brain Behav Immun. 2019;80:219–226.PMID: 30872091. doi: 10.1016/j.bbi.2019.03.009 [DOI] [PubMed] [Google Scholar]
- 16.Hasan W, Jama A, Donohue T, et al. Sympathetic hyperinnervation and inflammatory cell NGF synthesis following myocardial infarction in rats. Brain Res. 2006;1124(1):142–154.PMID: 17084822; PMCID: PMC1769447. doi: 10.1016/j.brainres.2006.09.054 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Crock LW, Rodgers R, Huck NA, et al. Chronic pain and complex regional pain syndrome are associated with alterations to the intestinal microbiota in both humans and mice. Neurobiol Pain. 2024;16:100173. doi: 10.1016/j.ynpai.2024.100173 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Tao R, Mi B, Hu Y, et al. Hallmarks of peripheral nerve function in bone regeneration. Bone Res. 2023;11:6. doi: 10.1038/s41413-022-00240-x [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Sun W, Ye B, Chen S, et al. Neuro–bone tissue engineering: emerging mechanisms, potential strategies, and current challenges. Bone Res. 2023;11:65. doi: 10.1038/s41413-023-00302-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Chang L, Yamamoto N. Molecular mechanisms of lesion-induced axonal sprouting in the corticofugal projection: the role of glial cells. Neural Regen Res. 2023;18(6):1259–1260. doi: 10.4103/1673-5374.360168 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Togari A, Arai M. Pharmacological topics of bone metabolism: the physiological function of the sympathetic nervous system in modulating bone resorption. J Pharmacol Sci. 2008;106(4):542–546. doi: 10.1254/jphs.FM0070227 [DOI] [PubMed] [Google Scholar]
- 22.Dworsky-Fried Z, Kerr BJ, Taylor AMW, et al. Microbes, microglia, and pain. Neurobiol Pain. 2020;7:100045. doi: 10.1016/j.ynpai.2020.100045 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Muschter D, Schäfer N, Stangl H, Straub RH, Grässel S. Sympathetic neurotransmitters modulate osteoclastogenesis and osteoclast activity in the context of collagen-induced arthritis. PLoS One. 2015;10(10):e0139726. doi: 10.1371/journal.pone.0139726 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Sato T, Arai M, Goto S, Togari A. Effects of propranolol on bone metabolism in spontaneously hypertensive rats. J Pharmacol Exp Ther. 2010;334(1):99–105. doi: 10.1124/jpet.110.167643 [DOI] [PubMed] [Google Scholar]
- 25.Fonseca TL, Jorgetti V, Costa CC, et al. Double disruption of alpha2A- and alpha2C-adrenoceptors results in sympathetic hyperactivity and high-bone-mass phenotype. J Bone Miner Res. 2011;26(3):591–603. doi: 10.1002/jbmr.243 [DOI] [PubMed] [Google Scholar]
- 26.Kondo H, Takeuchi S, Togari A. Beta-adrenergic signaling stimulates osteoclastogenesis via reactive oxygen species. Am J Physiol Endocrinol Metab. 2013;304(5):E507–E515. doi: 10.1152/ajpendo.00191.2012 [DOI] [PubMed] [Google Scholar]
- 27.Arai M, Nagasawa T, Koshihara Y, Yamamoto S, Togari A. Effects of beta-adrenergic agonists on bone-resorbing activity in human osteoclast-like cells. Biochim Biophys Acta. 2003;1640(2–3):137–142. doi: 10.1016/S0167-4889(03)00042-9 [DOI] [PubMed] [Google Scholar]
- 28.Vasconcelos e Cruz J, Notter F, Schick F, Lechner J. Comparison of cytokine RANTES/CCL5 inflammation in apical periodontitis and in jawbone cavitations. J Inflamm Res. 2024;17:67–80. doi: 10.2147/JIR.S442693 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Lechner J, McMahon R, Bouquot JE, Notter F, Schick F. Is preexisting inflamed jaw marrow a “hidden” comorbidity affecting outcomes of COVID-19 infections? Int J Immunopathol Pharmacol. 2024;38:03946320241265265. doi: 10.1177/03946320241265265 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Lechner J, Zimmermann B, Schmidt M, von Baehr V. Ultrasound sonography to detect focal osteoporotic jawbone marrow defects. Clin Cosmet Investig Dent. 2020;12:205–216. doi: 10.2147/CCIDE.S247345 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Bouquot JE, Shankland WE, Margolis M. Through-transmission alveolar ultrasonography (TAU). Oral Surg, Oral Med Oral Pathol Oral Radiol Endod. 2002;93. [Google Scholar]
- 32.Al-Nawas B, Grotz KA, Kann P. Ultrasound transmission velocity of the irradiated jaw bone in vivo. Clin Oral Investig. 2001;5:266–268. doi: 10.1007/s00784-001-0133-4 [DOI] [PubMed] [Google Scholar]
- 33.Al-Nawas B, Klein MO, Götz H, et al. Dental implantation: ultrasound transmission velocity to evaluate critical bone quality—an animal model. Ultraschall Med. 2008;29(3):302–307. doi: 10.1055/s-2006-927218 [DOI] [PubMed] [Google Scholar]
- 34.Klein MO, Grötz KA, Manefeld B, Kann PH, Al-Nawas B. Ultrasound transmission velocity for non-invasive evaluation of jaw bone quality in vivo prior to dental implantation. Ultrasound Med Biol. 2008;34:1966–1971. doi: 10.1016/j.ultrasmedbio.2008.04.016 [DOI] [PubMed] [Google Scholar]
- 35.Huber R, Choukroun E, Fahrenholz H, Notter F. Dental ultrasonography for visualizing osteoimmune conditions and assessing jaw bone density: a narrative review. Med Devices. 2025;18:1–13. doi: 10.2147/MDER.S491331 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Lechner J, von Baehr V. Peripheral Neuropathic Facial/Trigeminal Pain and RANTES/CCL5 in Jawbone Cavitation. Evid Based Complement Alternat Med. 2015;2015:1–9. doi: 10.1155/2015/582520 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Bouquot JE, McMahon RE, Glueck CJ. Ischemic osteonecrosis of the jaws: a possible link to systemic disorders. Oral Surg, Oral Med Oral Pathol Oral Radiol Endod. 2001;91(6):631–637. [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
The authors declare that all relevant data supporting the findings of this review are included in this article. For further requests, the corresponding author should be contacted.
